Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Steroid treatment greatly improved the symptoms of a boy with a rare disorder called Satoyoshi syndrome.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

The combination therapy was effective and well-tolerated, especially in young patients.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Transferosomes effectively deliver drugs through the skin, improving treatment for skin disorders.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Baricitinib improved hair loss and arthritis in a lupus patient.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.